HER2 FPBMC

· University of Virginia

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HER2 FPBMC, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) [Phase 1, Phase 2]